BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 30092830)

  • 1. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
    Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
    Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperactive CREB signaling pathway involved in the pathogenesis of polycystic ovarian syndrome revealed by patient-specific induced pluripotent stem cell modeling.
    Huang CC; Chen MJ; Lan CW; Wu CE; Huang MC; Kuo HC; Ho HN
    Fertil Steril; 2019 Sep; 112(3):594-607.e12. PubMed ID: 31277818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and adipocyte differentiation of polycystic ovary syndrome-derived induced pluripotent stem cells.
    Yang S; Ding S; Jiang X; Sun B; Xu Q
    Cell Prolif; 2016 Jun; 49(3):352-61. PubMed ID: 27108524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signaling.
    Lan CW; Chen MJ; Tai KY; Yu DC; Yang YC; Jan PS; Yang YS; Chen HF; Ho HN
    Sci Rep; 2015 Oct; 5():14994. PubMed ID: 26459919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
    Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
    Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
    Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
    Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of mitochondrial dysfunction on energy metabolism switch by HIF-1α signalling in granulosa cells of polycystic ovary syndrome.
    Wang J; Wu X
    Endokrynol Pol; 2020; 71(2):134-145. PubMed ID: 32096549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive assessment the expression of core elements related to IGFIR/PI3K pathway in granulosa cells of women with polycystic ovary syndrome.
    He T; Liu Y; Zhao S; Liu H; Wang Z; Shi Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():134-140. PubMed ID: 30594023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles for long non-coding RNAs in ovarian granulosa cells from women with PCOS with or without hyperandrogenism.
    Jin L; Yang Q; Zhou C; Liu L; Wang H; Hou M; Wu Y; Shi F; Sheng J; Huang H
    Reprod Biomed Online; 2018 Nov; 37(5):613-623. PubMed ID: 30224242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells derived from patients carrying mitochondrial mutations exhibit altered bioenergetics and aberrant differentiation potential.
    Meshrkey F; Scheulin KM; Littlejohn CM; Stabach J; Saikia B; Thorat V; Huang Y; LaFramboise T; Lesnefsky EJ; Rao RR; West FD; Iyer S
    Stem Cell Res Ther; 2023 Nov; 14(1):320. PubMed ID: 37936209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS).
    Khatun M; Lundin K; Naillat F; Loog L; Saarela U; Tuuri T; Salumets A; Piltonen TT; Tapanainen JS
    Stem Cell Rev Rep; 2024 Jan; 20(1):67-87. PubMed ID: 37768523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial and glucose metabolic dysfunctions in granulosa cells induce impaired oocytes of polycystic ovary syndrome through Sirtuin 3.
    Zhang Q; Ren J; Wang F; Pan M; Cui L; Li M; Qu F
    Free Radic Biol Med; 2022 Jul; 187():1-16. PubMed ID: 35594990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA expression profiling of granulosa cells in women of reproductive age with polycystic ovary syndrome.
    Zhang C; Liu J; Lai M; Li J; Zhan J; Wen Q; Ma H
    Arch Gynecol Obstet; 2019 Aug; 300(2):431-440. PubMed ID: 30937532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes.
    Horikoshi Y; Yan Y; Terashvili M; Wells C; Horikoshi H; Fujita S; Bosnjak ZJ; Bai X
    Cells; 2019 Sep; 8(9):. PubMed ID: 31533262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of ferroptosis-related genes in granulosa cells associates with impaired oocyte quality in polycystic ovary syndrome.
    Huang J; Fan H; Li C; Yang K; Xiong C; Xiong S; Feng S; Chen S; Wang B; Su Y; Xu B; Yang H; Wang N; Zhu J
    Front Endocrinol (Lausanne); 2024; 15():1346842. PubMed ID: 38390208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.
    Kaur S; Archer KJ; Devi MG; Kriplani A; Strauss JF; Singh R
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E2016-21. PubMed ID: 22904171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Several critical genes and microRNAs associated with the development of polycystic ovary syndrome.
    Wang W; Ji J; Li J; Ren Q; Gu J; Zhao Y; Hong D; Guo Q; Tan Y
    Ann Endocrinol (Paris); 2020 Feb; 81(1):18-27. PubMed ID: 32127169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.